- Home
- MDIA vs LUCD Comparison
MDIA vs LUCD Comparison
Compare MDIA & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDIA
- LUCD
- Stock Information
- Founded
- MDIA 2019
- LUCD 2018
- Country
- MDIA United States
- LUCD United States
- Employees
- MDIA N/A
- LUCD N/A
- Industry
- MDIA Broadcasting
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MDIA Consumer Discretionary
- LUCD Health Care
- Exchange
- MDIA Nasdaq
- LUCD Nasdaq
- Market Cap
- MDIA 55.6M
- LUCD 51.6M
- IPO Year
- MDIA N/A
- LUCD 2021
- Fundamental
- Price
- MDIA $1.09
- LUCD $1.22
- Analyst Decision
- MDIA
- LUCD Strong Buy
- Analyst Count
- MDIA 0
- LUCD 4
- Target Price
- MDIA N/A
- LUCD $3.63
- AVG Volume (30 Days)
- MDIA 16.4K
- LUCD 986.1K
- Earning Date
- MDIA 03-31-2025
- LUCD 03-24-2025
- Dividend Yield
- MDIA N/A
- LUCD N/A
- EPS Growth
- MDIA N/A
- LUCD N/A
- EPS
- MDIA N/A
- LUCD N/A
- Revenue
- MDIA $69,296,000.00
- LUCD $4,189,000.00
- Revenue This Year
- MDIA N/A
- LUCD $91.72
- Revenue Next Year
- MDIA N/A
- LUCD $139.38
- P/E Ratio
- MDIA N/A
- LUCD N/A
- Revenue Growth
- MDIA 94.96
- LUCD 179.27
- 52 Week Low
- MDIA $0.40
- LUCD $0.63
- 52 Week High
- MDIA $6.86
- LUCD $1.63
- Technical
- Relative Strength Index (RSI)
- MDIA 44.65
- LUCD 46.35
- Support Level
- MDIA $1.00
- LUCD $1.27
- Resistance Level
- MDIA $1.23
- LUCD $1.47
- Average True Range (ATR)
- MDIA 0.08
- LUCD 0.16
- MACD
- MDIA -0.00
- LUCD -0.04
- Stochastic Oscillator
- MDIA 38.46
- LUCD 15.59
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales and events including sponsorships and ticket sales, licensing, and syndication.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.